Psoriasis registries worldwide: systematic overview on registry publications
- 2 May 2016
- journal article
- review article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 30 (7) , 1100-1106
Abstract
Background: Safety and efficacy of new treatments are analyzed in clinical trials but their capacity to show potential effects of long‐term treatment and more than short latency of onset is limited. To meet this challenge, patient registries (of treatments or diseases) collect prospective data of real‐world patients in daily practice without tight selection of patients.Objective: The aim of this article was to identify existing psoriasis patient registries by published articles and evaluation of monitored treatment classes, patients, research questions addressed, and measurement instruments implemented.Materials & Methods: A systematic review of Medline (PubMed) and Embase (Ovid) databases for publications on psoriasis patient registries, including cross‐validation was conducted October 2015.Results: 14 patient registries for long‐term observation of psoriasis patients in real‐world care were identified. Registries were established since 2005, the majority is located in Europe. The number of published studies from single registries ranged from 1 to 10. Most registries include patients treated by conventional systemics as well as biologics. The number of patients analyzed ranged from 35 to >12 000 patients. The publications mostly addressed safety issues or treatment outcomes, followed by baseline description, drug survival, predictor analyses, and treatment patterns.Conclusion: A variety of local, national, and international patient registries collect longitudinal data on (systemic) psoriasis treatment. The number of publications reflect the main registry objectives of safety and effectiveness, with additional therapy‐related investigations being addressed as well. Based on the information from publications, the combination of data from these registries will involve many methodological challenges. To gain comparability and combinability of cohorts and data across registries, further harmonization of data collection is demanded.Keywords
This publication has 53 references indexed in Scilit:
- Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registryJournal of the European Academy of Dermatology and Venereology, 2014
- Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the Biobadaderm registryJournal of the European Academy of Dermatology and Venereology, 2014
- Systemic psoriasis therapy shows high between-country variation: a sign of unwarranted variation? Cross-sectional analysis of baseline data from the PSONET registriesBritish Journal of Dermatology, 2013
- Global Epidemiology of Psoriasis: A Systematic Review of Incidence and PrevalenceJournal of Investigative Dermatology, 2013
- Latent tuberculosis infection and active tuberculosis in patients with psoriasis: a study on the incidence of tuberculosis and the prevalence of latent tuberculosis disease in patients with moderate–severe psoriasis in Spain. BIOBADADERM registryJournal of the European Academy of Dermatology and Venereology, 2012
- Challenges for Synthesising Data in a Network of Registries for Systemic Psoriasis TherapiesDermatology, 2012
- Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare RegistryJournal of the European Academy of Dermatology and Venereology, 2012
- Epidemiologie der Psoriasis in Deutschland - Auswertung von Sekundärdaten einer gesetzlichen KrankenversicherungDas Gesundheitswesen, 2010
- National Registries of Systemic Treatment for Psoriasis and the European ‘Psonet’ InitiativeDermatology, 2008
- Psoriasis Therapy in Real Life: The Need for RegistriesDermatology, 2006